MOREPENLAB — Morepen Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Morepen Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,468	14,175	16,904	18,116	18,057
Cost of Revenue
Gross Profit	4,670	4,234	5,728	5,853	6,374
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,378	13,659	15,653	16,665	16,907
Operating Profit	1,090	516	1,252	1,451	1,150
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,267	558	1,354	1,551	1,199
Provision for Income Taxes
Net Income After Taxes	1,017	387	966	1,180	956
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,017	387	962	1,180	949
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,017	387	962	1,180	949
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.96	0.77	1.88	2.2	1.36
Dividends per Share